Efficacy and Safety of Pembrolizumab Monotherapy in Patients With Advanced Thyroid Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study
Cancer 2023 Feb 07;[EPub Ahead of Print], DY Oh, A Algazi, J Capdevila, F Longo, W Miller, JT Chun Bing, CE Bonilla, HC Chung, TK Guren, CC Lin, D Motola-Kuba, M Shah, J Hadoux, L Yao, F Jin, K Norwood, L LebellecFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.